(Bloomberg) -- BC Partners is nearing a deal to sell Dutch generic drugmaker Synthon International Holding BV to Goldman Sachs Asset Management, according to people familiar with the matter.

Goldman Sachs Asset Management (GSAM), the alternative investment division of Goldman Sachs Group Inc., has entered into an agreement to acquire a controlling stake in Dutch generic drug manufacturer ...